CN104892580B - 一种新型苯并咪唑‑嘧啶胺衍生物、及其应用 - Google Patents
一种新型苯并咪唑‑嘧啶胺衍生物、及其应用 Download PDFInfo
- Publication number
- CN104892580B CN104892580B CN201510338817.4A CN201510338817A CN104892580B CN 104892580 B CN104892580 B CN 104892580B CN 201510338817 A CN201510338817 A CN 201510338817A CN 104892580 B CN104892580 B CN 104892580B
- Authority
- CN
- China
- Prior art keywords
- acid
- compound
- cancer
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CC(C)NC(*C1CC(Cc2nc(NCN=CCC(CCN3*CCN(CCC(*)(*)C*)CC3)=CC#C)ncc2F)C2)C(C)=NC1[C@@]2F Chemical compound CC(C)NC(*C1CC(Cc2nc(NCN=CCC(CCN3*CCN(CCC(*)(*)C*)CC3)=CC#C)ncc2F)C2)C(C)=NC1[C@@]2F 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510338817.4A CN104892580B (zh) | 2015-06-17 | 2015-06-17 | 一种新型苯并咪唑‑嘧啶胺衍生物、及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510338817.4A CN104892580B (zh) | 2015-06-17 | 2015-06-17 | 一种新型苯并咪唑‑嘧啶胺衍生物、及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104892580A CN104892580A (zh) | 2015-09-09 |
CN104892580B true CN104892580B (zh) | 2018-01-26 |
Family
ID=54025594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510338817.4A Active CN104892580B (zh) | 2015-06-17 | 2015-06-17 | 一种新型苯并咪唑‑嘧啶胺衍生物、及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104892580B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106467517B (zh) * | 2015-08-14 | 2019-09-06 | 正大天晴药业集团股份有限公司 | 氘修饰的Abemaciclib衍生物 |
WO2018019204A1 (zh) | 2016-07-26 | 2018-02-01 | 深圳市塔吉瑞生物医药有限公司 | 用于抑制蛋白酪氨酸激酶活性的氨基嘧啶类化合物 |
CN108675993A (zh) * | 2018-06-14 | 2018-10-19 | 纽瑞森生物科技(北京)有限公司 | 氘代嘧啶类化合物、制备方法、药物组合物、制剂和用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO2885B1 (en) * | 2008-12-22 | 2015-03-15 | ايلي ليلي اند كومباني | Protein kinase inhibitors |
-
2015
- 2015-06-17 CN CN201510338817.4A patent/CN104892580B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104892580A (zh) | 2015-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105461695B (zh) | 嘧啶或三嗪衍生物及其制备方法和用途 | |
CN107922348A (zh) | 双环杂环酰胺衍生物 | |
CN104892580B (zh) | 一种新型苯并咪唑‑嘧啶胺衍生物、及其应用 | |
CN109575025A (zh) | 取代的吡唑并[1,5-a]嘧啶类的大环化合物 | |
CN105209040A (zh) | 大环的盐可诱导的激酶抑制剂 | |
CN102971312A (zh) | 吡咯取代的2-二氢吲哚酮衍生物、其制备方法及用途 | |
CN110343090A (zh) | 喹唑啉衍生物盐型晶型及制备方法和应用 | |
US10323035B2 (en) | Co-crystal of a CDK inhibitor and an MEK inhibitor and process of preparation thereof | |
CN104003925B (zh) | 吲哚酮化合物或其衍生物及其用途 | |
CN107674056B (zh) | 芹菜素衍生物其在治疗高尿酸血症中的应用 | |
CN110922415B (zh) | 一种新型抗肿瘤活性化合物的合成与应用 | |
CN105601617A (zh) | 一种邻二氮杂环化合物及其制备方法与应用 | |
CN105175309A (zh) | N-苄基-5/6-甲酰氨基吲哚-2-羧酸衍生物及其用途 | |
CN103382195A (zh) | 苯并吡喃查尔酮类化合物及其制备方法和用途 | |
CN108299420A (zh) | 作为选择性***受体下调剂的五环类化合物及其应用 | |
CN107879975A (zh) | 组蛋白去乙酰化酶抑制剂及其应用 | |
CN110407854A (zh) | 新的四环化合物 | |
CN106397408A (zh) | 5-甲基-2(1h)吡啶酮衍生物及其制备方法和用途 | |
CN113444074B (zh) | 一种具有EGFR和Wnt双重抑制作用的化合物及其制备方法和应用 | |
CN107739381A (zh) | 莪术醇衍生物及其在制备抗肿瘤药物中的应用 | |
CN114306255A (zh) | 一种甲基酮类衍生物药物制剂及其制备方法 | |
CN102827124A (zh) | 香豆素类衍生物及其药物组合物及用途 | |
CN103965180B (zh) | 苯磺酰胺噁唑和噻唑激酶抑制剂 | |
CN108484635B (zh) | 4H-噻吩并[2,3-b]噻喃-4-酮类化合物及其应用 | |
CN104402875A (zh) | N-(2-氨基乙基)-n′-(6-取代-2-苯并噻唑基)脲及其盐类化合物的合成方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20171228 Address after: Private Economic Development Zone Zhenjiang city Jiangsu province 212000 Runzhou District run Hing Road East Applicant after: Zhenjiang Sheng'an Pharmaceutical Co., Ltd. Address before: 212000 Zhenjiang City, Jiangsu province Jiefang Road Jingkou District No. 19 Building 1 Room 403 Applicant before: Peng Kuai |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180926 Address after: 450046 No. 957, A seat, Newton international, middle Jin Yang Road, Jinshui District, Zhengzhou, Henan Patentee after: Henan inno Medicine Technology Co., Ltd. Address before: 212000 east side of run Xing Road, run economic zone, Zhenjiang, Jiangsu Patentee before: ZHENJIANG SHENGAN PHARMACEUTICAL CO., LTD. |